ARCHIVES

DCT Advisors Approve Recompetition Of Drug Discovery Groups

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

New Two-Step Matching Process Increases Success of Transplants

September 30, 2011

Medical Advances Not Driven Entirely By Science, Author Physician Barron Lerner Tells Journalists

March 22, 2002

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

October 21, 2011